Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company focused on pioneering life-changing medicines for brain health disorders. Their mission centers on creating innovative therapies to improve the lives of individuals affected by these conditions. They are committed to addressing unmet needs, starting with their focus on maternal mental health, and have brought the only FDA-approved treatments for postpartum depression to market. Their pioneering science is also targeting other brain health disorders like cognitive impairment associated with neurodegenerative diseases.

Sage prioritizes a patient-centric approach, integrating their perspectives into every stage of their work, from research through commercialization. This commitment extends beyond their scientific endeavors to include their corporate social responsibility initiatives, which include supporting researchers, community-based organizations, and families facing hardship through grants, sponsorships, and volunteerism. Sage is committed to fostering a sustainable workplace and supporting their employees through a variety of programs and benefits.

Sage Therapeutics offers flexible work arrangements through their "SageFlex" program, allowing employees to work remotely, in the office, or a combination of both. This flexibility is adaptable to individual needs and preferences, enabling employees to choose the work environment that best suits their lifestyle and work style.

Sage Therapeutics offers a comprehensive benefits package designed to support employees' well-being and cater to their diverse needs. Benefits include health insurance, dental and vision coverage, paid time off, parental leave, life insurance, disability insurance, a 401(k) plan with company matching, and access to employee assistance programs. Sage also offers flexible work arrangements, including the SageFlex program, which allows employees to work remotely, in the office, or a combination of both, promoting work-life balance and employee satisfaction.

Sage Therapeutics is a biopharmaceutical company committed to pioneering life-changing brain health medicines for individuals suffering from a range of brain health disorders. They aim to transform the understanding and treatment of these conditions by developing novel therapies that address unmet medical needs and ultimately improve the lives of patients and their families.

Sage Therapeutics cultivates a culture of unconventional thinking and innovation, where employees are encouraged to challenge the status quo and embrace new ideas to address brain health disorders. The company emphasizes the importance of putting people first, both patients and employees, while fostering a supportive and inclusive environment that promotes well-being and a strong sense of purpose. The company values diversity, equity, and inclusion, believing that a diverse workforce drives innovation and better serves patients.

Sage Therapeutics sees diversity, equity, and inclusion (DE&I) as a core value that goes beyond initiatives and is woven into the fabric of the company. They believe DE&I is essential for their patients, employees, business success, and personal values. Sage actively strives to foster a diverse and inclusive culture that embraces differences, ensures equitable opportunities, and prioritizes building authentic relationships. They actively recruit and develop diverse talent, partner with diverse community organizations and vendors, and ensure diverse voices are heard in their partnerships.